Technology area: Biotechnology & Pharmaceuticals
13 pending office actions • 12 art units • 13 examiners • 0 of 13 (0%) have an AI response strategy ready • 14 patents granted in the last 365 days
UNIVERSITE DE PARIS-SACLAY has 1 pending office action in Biotechnology & Pharmaceuticals. The matter is assigned to 1 distinct examiner and 1 distinct art unit.
WARD, AARON DUREL is the busiest examiner, with 1 pending matter. The profile presents one focused biotechnology prosecution path. Counsel can concentrate on examiner-specific claim and prior-art analysis for the identified art unit.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 3 (23%) |
| §103 only | 5 (38%) |
| Multi-statute (no §101) | 5 (38%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LIEW, ALEX KOK SOON | 1 | 87.7% | +7.2% |
| LIPPERT, JOHN WILLIAM | 1 | 59.2% | +39.9% |
| OSENBAUGH-STEWART, ELIZA W | 1 | 73.0% | +16.8% |
| VARNDELL, ROSS E | 1 | 84.7% | +13.2% |
| GRANT, MICHAEL CHRISTOPHER | 1 | 22.0% | +7.1% |
| KAMM, JUDITH MARIE | 1 | 42.9% | +57.1% |
| HAUT, EVAN HARRISON | 1 | 57.1% | +0.0% |
| WOLDEMARYAM, ASSRES H | 1 | 82.2% | +13.1% |
| HOFFMAN, ALEXANDER JOSEPH | 1 | 0.0% | +0.0% |
| ROBINSON, HOPE A | 1 | 67.7% | +43.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19099359 | COMPUTER-IMPLEMENTED METHOD OF LIVER RESECTION PLANNING | LIEW, ALEX KOK SOON | — |
| 18722116 | WIDE-FIELD-OF-VIEW STATIC LIDAR | WOLDEMARYAM, ASSRES H | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18008298 | Method for generating a decision support system and associated systems | BOSTWICK, SIDNEY VINCENT | 8d overdue |
| 18262523 | DETECTING BETA-LACTAMASE ENZYME ACTIVITY | REGLAS, GEORGIANA C | 5d overdue |
| 18698789 | KYNURENINE AMINOTRANSFERASE AND PRODUCTS THEREOF FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES | ROBINSON, HOPE A | 2d overdue |
| 18967572 | DEVICE, APPARATUS AND METHOD FOR MINIBEAM RADIATION THERAPY | OSENBAUGH-STEWART, ELIZA W | — |
| 18863355 | METHOD FOR PROCESSING 3D IMAGING DATA AND ASSISTING WITH PROGNOSIS OF CANCER | VARNDELL, ROSS E | — |
| 18906825 | METHOD AND SYSTEM FOR TESTING COGNITION BY PROCESSING THE REACTION OF A SUBJECT TO STIMULI | GRANT, MICHAEL CHRISTOPHER | — |
| 18799390 | NOVEL NANOPARTICLES OF ANTIRETROVIRAL DRUGS, THEIR PREPARATION AND THEIR USE FOR THE TREATMENT OF VIRAL INFECTIONS | KAMM, JUDITH MARIE | — |
| 18708619 | PRODUCTS AND USES THEREOF FOR PREDICTING THE SENSITIVITY OF A SUBJECT TO CANCER IMMUNOTHERAPY AND FOR SELECTING OPTIMIZED THERAPY | HOFFMAN, ALEXANDER JOSEPH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18698789 | KYNURENINE AMINOTRANSFERASE AND PRODUCTS THEREOF FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES | ROBINSON, HOPE A | 2d overdue |
| 18879667 | RADIOPAQUE MONOMER AND EMBOLISATION MICROSPHERES COMPRISING SAME | LIPPERT, JOHN WILLIAM | — |
| 18967572 | DEVICE, APPARATUS AND METHOD FOR MINIBEAM RADIATION THERAPY | OSENBAUGH-STEWART, ELIZA W | — |
| 18863355 | METHOD FOR PROCESSING 3D IMAGING DATA AND ASSISTING WITH PROGNOSIS OF CANCER | VARNDELL, ROSS E | — |
| 18799390 | NOVEL NANOPARTICLES OF ANTIRETROVIRAL DRUGS, THEIR PREPARATION AND THEIR USE FOR THE TREATMENT OF VIRAL INFECTIONS | KAMM, JUDITH MARIE | — |
| 18722116 | WIDE-FIELD-OF-VIEW STATIC LIDAR | WOLDEMARYAM, ASSRES H | — |
| Art Unit | Apps |
|---|---|
| 2674 | 1 |
| 1615 | 1 |
| 2668 | 1 |
| 3715 | 1 |
| 1611 | 1 |
| 3645 | 1 |
| 3642 | 1 |
| 1677 | 1 |
| 1652 | 1 |
| 1651 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19099359 | COMPUTER-IMPLEMENTED METHOD OF LIVER RESECTION PLANNING | LIEW, ALEX KOK SOON | 2674 | §103 | Non-Final OA | — | Pending | Jan 28, 2025 |
| 18879667 | RADIOPAQUE MONOMER AND EMBOLISATION MICROSPHERES COMPRISING SAME | LIPPERT, JOHN WILLIAM | 1615 | §103Other | Non-Final OA | — | Pending | Dec 27, 2024 |
| 18967572 | DEVICE, APPARATUS AND METHOD FOR MINIBEAM RADIATION THERAPY | OSENBAUGH-STEWART, ELIZA W | — | §103§112 | Non-Final OA | — | Pending | Dec 03, 2024 |
| 18863355 | METHOD FOR PROCESSING 3D IMAGING DATA AND ASSISTING WITH PROGNOSIS OF CANCER | VARNDELL, ROSS E | 2668 | §103§112 | Non-Final OA | — | Pending | Nov 06, 2024 |
| 18906825 | METHOD AND SYSTEM FOR TESTING COGNITION BY PROCESSING THE REACTION OF A SUBJECT TO STIMULI | GRANT, MICHAEL CHRISTOPHER | 3715 | §101§112 | Non-Final OA | — | Pending | Oct 04, 2024 |
| 18799390 | NOVEL NANOPARTICLES OF ANTIRETROVIRAL DRUGS, THEIR PREPARATION AND THEIR USE FOR THE TREATMENT OF VIRAL INFECTIONS | KAMM, JUDITH MARIE | 1611 | §102§103§112Other | Non-Final OA | — | Pending | Aug 09, 2024 |
| 18722587 | IMPROVED WIDE-FIELD-OF-VIEW LIDAR | HAUT, EVAN HARRISON | 3645 | §103 | Non-Final OA | — | Pending | Jun 21, 2024 |
| 18722116 | WIDE-FIELD-OF-VIEW STATIC LIDAR | WOLDEMARYAM, ASSRES H | 3642 | §103 | Non-Final OA | — | Pending | Jun 20, 2024 |
| 18708619 | PRODUCTS AND USES THEREOF FOR PREDICTING THE SENSITIVITY OF A SUBJECT TO CANCER IMMUNOTHERAPY AND FOR SELECTING OPTIMIZED THERAPY | HOFFMAN, ALEXANDER JOSEPH | 1677 | §101§103§112 | Non-Final OA | — | Pending | May 09, 2024 |
| 18698789 | KYNURENINE AMINOTRANSFERASE AND PRODUCTS THEREOF FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES | ROBINSON, HOPE A | 1652 | §103§112 | Final Rejection | 2d overdue | Pending | Apr 05, 2024 |
| 18262523 | DETECTING BETA-LACTAMASE ENZYME ACTIVITY | REGLAS, GEORGIANA C | 1651 | §102§103 | Final Rejection | 5d overdue | Pending | Jul 21, 2023 |
| 18008298 | Method for generating a decision support system and associated systems | BOSTWICK, SIDNEY VINCENT | 2124 | §101§103§112 | Non-Final OA | 8d overdue | Pending | Dec 05, 2022 |
| 17779943 | FREEZE-DRIED POWDER CONTAINING 2-[(3-AMINOPROPYL)AMINO]ETHANETHIOL AND ITS USE FOR PREPARING A THERMOGEL | MOU, LIYUAN | 1628 | §103Other | Final Rejection | — | Pending | May 25, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUniversité Paris-Saclay has 13 pending office actions as of October 2026, spread across 12 art units and 13 examiners.
Alex Kok Soon Liew has the most, with 1 of Université Paris-Saclay's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
